Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Severe Restriction of Xenotropic Murine Leukemia Virus-Related Virus Replication and Spread in Cultured Human Peripheral Blood Mononuclear Cells
  2. Chaipan, C.; Dilley, K. A.; Paprotka, T.; Delviks-Frankenberry, K. A.; Venkatachari, N. J.; Hu, W. S.; Pathak, V. K.
  3. Journal of Virology. 2011, May; 85(10): 4888-4897.
  1. 2.   APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
  2. Reddy, K.; Winkler, C. A.; Werner, L.; Mlisana, K.; Karim, S. S. A.; Ndung'u, T.; Team, C. A. I. S.
  3. Aids. 2010, Jan; 24(2): 195-204.
  1. 3.   Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development
  2. Smith, J. L.; Bu, W.; Burdick, R. C.; Pathak, V. K.
  3. Trends in Pharmacological Sciences. 2009, Dec; 30(12): 638-646.
  1. 5.   A macaque model of HIV-1 infection
  2. Hatziioannou, T.; Ambrose, Z.; Chung, N.; Piatak, M.; Yuan, F.; Trubey, C. M.; Coalter, V.; Kiser, R.; Schneider, D.; Smedley, J.; Pung, R.; Gathuka, M.; Estes, J. D.; Veazey, R. S.; KewalRamani, V. N.; Lifson, J. D.; Bieniasz, P. D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(11): 4425-4429 DI 10.1073/pnas.
  1. 6.   Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference
  2. Rausch, J. W.; Chelico, L.; Goodman, M. F.; Le Grice, S.
  3. Journal of Biological Chemistry. 2009 284(11): 7047-7058.
  1. 8.   Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses
  2. Rulli, S. J.; Mirro, J.; Hill, S. A.; Lloyd, P.; Gorelick, R. J.; Coffin, J. M.; Derse, D.; Rein, A.
  3. Journal of Virology. 2008 82(13): 6566-6575.
  1. 9.   The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA(3)(Lys) annealing to viral RNA
  2. Guo, F.; Cen, S.; Niu, M. J.; Yang, Y. L.; Gorelick, R. J.; Kleiman, L.
  3. Journal of Virology. 2007, Oct; 81(20): 11322-11331.
  1. 10.   Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
  2. Neumann, A. U.; Polis, M. A.; Rozenberg, L.; Jackson, J. O.; Reitano, K. N.; McLaughlin, M.; Koratich, C.; Dewar, R. L.; Masur, H.; Haagmans, B. L.; Kottilil, S.
  3. Aids. 2007, Sep; 21(14): 1855-1865.
  1. 11.   Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
  2. Mbisa, J. L.; Barr, R.; Thomas, J. A.; Vandegraaff, N.; Dorweiler, I. J.; Svarovskaia, E. S.; Brown, W. L.; Mansky, L. M.; Gorelick, R. J.; Harris, R. S.; Engelman, A.; Pathak, V. K.
  3. Journal of Virology. 2007, Jul; 81(13): 7099-7110.
  1. 12.   Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions
  2. Xu, H. Z.; Chertova, E.; Chen, J. B.; Ott, D. E.; Roser, J. D.; Hu, W. S.; Pathak, V. K.
  3. Virology. 2007, Apr; 360(2): 247-256.
  1. 13.   Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
  2. Derse, D.; Hill, S. A.; Princler, G.; Lloyd, P.; Heidecker, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Feb; 104(8): 2915-2920.
  1. 14.   Polymorphisms of CUL5 are associated with CD4(+) T cell loss in HIV-1 infected individuals
  2. An, P.; Duggal, P.; Wang, L. H.; O'Brien, S. J.; Donfield, S.; Goedert, J. J.; Phair, J.; Buchbinder, S.; Kirk, G. D.; Winkler, C. A.
  3. Plos Genetics. 2007, Jan; 3(1):
  1. 15.   Intracellular restriction factors in mammalian cells - An ancient defense system finds a modern foe
  2. Baumann, J. G.
  3. Current HIV Research. 2006, Apr; 4(2): 141-168.
  1. 16.   Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
  2. Luo, K.; Liu, B. D.; Xiao, Z. X.; Yu, Y. K.; Yu, X. H.; Gorelick, R.; Yu, X. F.
  3. Journal of Virology. 2004, NOV; 78(21): 11841-11852.
  1. 17.   Murine T cells potently restrict human immunodeficiency virus infection
  2. Baumann, J. G.; Unutmaz, D.; Miller, M. D.; Breun, S. K. J.; Grill, S. M.; Mirro, J.; Littman, D. R.; Rein, A.; KewalRamani, V. N.
  3. Journal of Virology. 2004, NOV; 78(22): 12537-12547.
  1. 18.   APOBEC3G genetic variants and their influence on the progression to AIDS
  2. An, P.; Bleiber, G.; Duggal, P.; Nelson, G.; May, M.; Mangeat, B.; Alobwede, I.; Trono, D.; Vlahov, D.; Donfield, S.; Goedert, J. J.; Phair, J.; Buchbinder, S.; O'Brien, S. J.; Telenti, A.; Winkler, C. A.
  3. Journal of Virology. 2004, OCT; 78(20): 11070-11076.
  1. 19.   A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion
  2. Xu, H. Z.; Svarovskaia, E. S.; Barr, R.; Zhang, Y. J.; Khan, M. A.; Strebel, K.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(15): 5652-5657.
  1. 20.   Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
  2. Yu, Q.; Konig, R.; Pillai, S.; Chiles, K.; Kearney, M.; Palmer, S.; Richman, D.; Coffin, J. M.; Landau, N. R.
  3. Nature Structural & Molecular Biology. 2004 11(5): 435-442.
  1. 21.   Weapons of mutational destruction
  2. KewalRamani, V. N.; Coffin, J. M.
  3. Science. 2003 301(5635): 923-925.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel